LLY - Eli Lilly and Company Stock Price and Quote

LLY [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	49.13	EPS (ttm)	6.90	Insider Own	10.90%	Shs Outstand	950.18M	Perf Week	-1.01%
Market Cap	314.23B	Forward P/E	28.88	EPS next Y	11.74	Insider Trans	40.40%	Shs Float	948.37M	Perf Month	-6.09%
Income	6.24B	PEG	2.17	EPS next Q	1.72	Inst Own	84.80%	Short Float / Ratio	0.52% / 1.68	Perf Quarter	-6.80%
Sales	28.54B	P/S	11.01	EPS this Y	-9.80%	Inst Trans	0.68%	Short Interest	4.93M	Perf Half Y	11.86%
Book/sh	11.18	P/B	30.33	EPS next Y	38.80%	ROA	12.00%	Target Price	388.87	Perf Year	37.69%
Cash/sh	2.96	P/C	114.59	EPS next 5Y	22.64%	ROE	61.70%	52W Range	231.87 - 384.44	Perf YTD	-7.86%
Dividend	4.52	P/FCF	129.30	EPS past 5Y	18.90%	ROI	20.80%	52W High	-12.32%	Beta	0.34
Dividend %	1.33%	Quick Ratio	0.90	Sales past 5Y	5.90%	Gross Margin	76.80%	52W Low	45.37%	ATR	11.57
Employees	35000	Current Ratio	1.10	Sales Q/Q	2.50%	Oper. Margin	24.60%	RSI (14)	39.23	Volatility	3.23% 3.64%
Optionable	Yes	Debt/Eq	1.58	EPS Q/Q	31.80%	Profit Margin	19.90%	Rel Volume	0.80	Prev Close	339.08
Shortable	Yes	LT Debt/Eq	1.40	Earnings	Feb 02 BMO	Payout	58.10%	Avg Volume	2.93M	Price	337.07
Recom	2.00	SMA20	-3.40%	SMA50	-6.02%	SMA200	2.65%	Volume	761,529	Change	-0.59%

Nov-18-22

Initiated

Credit Suisse

Outperform

$395

Sep-22-22

Upgrade

UBS

Neutral → Buy

$335 → $363

May-23-22

Initiated

SVB Leerink

Outperform

$341

Apr-06-22

Resumed

Morgan Stanley

Overweight

$265 → $364

Mar-10-22

Initiated

Daiwa Securities

Outperform

$286

Jan-21-22

Upgrade

DZ Bank

Hold → Buy

$291

Jan-03-22

Reiterated

Bernstein

Mkt Perform

$250 → $300

Dec-17-21

Initiated

Goldman

Neutral

$236

Dec-16-21

Reiterated

BofA Securities

Buy

$285 → $300

Dec-16-21

Reiterated

BMO Capital Markets

Outperform

$311 → $320

Show Previous Ratings

Feb-06-23 10:40AM	Eli Lilly Stock Shows Rising Relative Strength Following Downturn Investor's Business Daily
06:05AM	Drug companies face COVID cliff in 2023 as sales set to plummet Reuters
06:00AM	FOCUS-Drug companies face COVID cliff in 2023 as sales set to plummet Reuters
Feb-05-23 11:40AM	Eli Lilly and Company (NYSE:LLY) Q4 2022 Earnings Call Transcript Insider Monkey
08:46AM	12 Safe Stocks to Buy For Long-Term Insider Monkey
05:31PM	Loading…
Feb-03-23 05:31PM	AbbVie Q4 Preview: What's in Store? Zacks
01:19PM	10 Hot Healthcare Stocks To Buy Now Insider Monkey
10:00AM	Lilly to Participate in Guggenheim Oncology Conference PR Newswire
09:19AM	Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits Zacks
08:38AM	Eli Lilly's (NYSE:LLY) Upcoming Dividend Will Be Larger Than Last Year's Simply Wall St.
06:56AM	Lilly (LLY) Reports Q4 Earnings: What Key Metrics Have to Say Zacks
Feb-02-23 08:00PM	Eli Lilly (LLY) Q4 2022 Earnings Call Transcript Motley Fool
07:49PM	Analyst Report: Eli Lilly and Company Morningstar Research
06:29PM	COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst Yahoo Finance
04:09PM	Eli Lilly Dives After A 'Bump In The Road' Shakes Its Newest Diabetes Drug Investor's Business Daily
04:00PM	Loading…
04:00PM	US STOCKS-Nasdaq, S&P 500 close higher on Meta bump, Fed lift Reuters
03:19PM	Merck, Eli Lilly stocks fall over earnings, outlook concerns Yahoo Finance Video
02:36PM	US STOCKS-Nasdaq, S&P 500 jump on Meta rise, Fed relief Reuters
02:03PM	Lilly (LLY) Beats on Q4 Earnings, Lags on Sales, Raises '23 View Zacks
01:54PM	Analyst Report: Eli Lilly and Company Morningstar Research
12:15PM	Why Eli Lilly Stock Is Under Pressure Today Motley Fool
12:07PM	Pharma earnings: COVID is highly uncertain for this year, analyst says Yahoo Finance Video
11:50AM	Why Obesity-Drug Makers Just Lost Weight The Wall Street Journal
11:04AM	Economic Data Deluge Zacks
10:41AM	Eli Lilly Stock Falls as Mounjaro Sales Fall Short. Earnings Still Crushed. Barrons.com
10:39AM	Goldilocks Econ Data Presides Over Pre-Market Zacks
10:36AM	Eli Lilly Posts Weaker Q4 Sales On Slower Demand For Its COVID-19 Treatment, Overshadowing Annual Guidance Benzinga
08:58AM	Eli Lilly Sinks On Mixed Earnings Report, But Boosts 2023 Earnings Outlook Investor's Business Daily
08:05AM	Eli Lilly (LLY) Q4 Earnings Surpass Estimates Zacks
08:05AM	Eli Lilly Stock Slips as Hyped-Up Obesity Drug Sales Fall Short. Earnings Crush Estimates. Barrons.com
07:31AM	Loading…
07:31AM	Eli Lilly Earnings Show 9% Sales Drop on Covid-19 Treatment Decline The Wall Street Journal
07:18AM	Eli Lillys stock falls after Q4 revenue miss MarketWatch
07:03AM	Eli Lilly Stock Falls Even as Earnings Crush Estimates Barrons.com
07:02AM	Eli Lilly Tops Q4 Earnings Forecast, Lifts 2023 Outlook, On Trulicity Strength TheStreet.com
07:01AM	UPDATE 3-Eli Lilly's weak fourth-quarter sales cloud 2023 profit forecast Reuters
07:00AM	Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint The Wall Street Journal
06:53AM	Eli Lilly's weak fourth-quarter sales cloud 2023 profit forecast Reuters
06:51AM	Eli Lilly raises 2023 profit forecast Reuters
06:45AM	Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook PR Newswire
Feb-01-23 01:56PM	Jim Cramer Gushes Over Pharmaceutical Stock's Chart: 'About The Greatest You've Ever Seen' TheStreet.com
10:44AM	Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others Zacks
09:53AM	Why the FDA's Rejection of Eli Lilly's Alzheimer's Drug Is Actually Great News for the Stock Motley Fool
Jan-31-23 04:38PM	UPDATE 1-Amgen revenue falls slightly as Lilly COVID deal contributes less Reuters
04:04PM	Amgen revenue falls slightly as Lilly COVID deal contributes less Reuters
04:01PM	Amgen revenue falls slightly as Lilly COVID deal contributes less Reuters
06:00AM	Eli Lilly (NYSE:LLY) shareholders have earned a 37% CAGR over the last five years Simply Wall St.
Jan-30-23 10:11AM	Eli Lilly (LLY) Lymphoma Candidate Pirtobrutinib Gets FDA Nod Zacks
07:11AM	FDA Gives Conditional Approval For Eli Lilly's Drug For Rare Blood Cancer Benzinga
06:59AM	Heres Why Eli Lilly and Company (LLY) Rose in Q4 Insider Monkey
Jan-29-23 09:06PM	Why Eli Lilly is tagging the Research Triangle for long-term growth American City Business Journals
Jan-27-23 02:27PM	UPDATE 1-FDA approves Eli Lilly's blood cancer drug Reuters
02:07PM	U.S. FDA Approves Jaypirca (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor PR Newswire
10:26AM	FDA Pulls EUA Granted to AstraZeneca's (AZN) Evusheld Zacks
09:57AM	Biogen (BIIB) & Eisai's Lecanemab Secures EMA's MAA Acceptance Zacks
08:23AM	Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards? Zacks
08:14AM	Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends Zacks
06:50AM	3 Healthcare Stocks to Buy and Hold for the Next 10 Years Motley Fool
Jan-26-23 10:25AM	Lilly Supports Direct Reliefs Efforts To Expand Access to Medicines by Improving Cold Chain Capacity ACCESSWIRE
10:15AM	Could This New Drug Indication Be a Winner for Eli Lilly? Motley Fool
10:00AM	Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity PR Newswire
09:38AM	Is It Too Late to Buy Eli Lilly Stock? Motley Fool
09:00AM	Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know Zacks
07:40AM	WFU receives $30M grant from the Lilly Endowment to create national network for character education American City Business Journals
06:53AM	Dow, IBM, and SAP Keep the Layoffs Coming. Its Spreading Beyond Tech. Barrons.com
Jan-25-23 08:27PM	Why the Dip in Cassava Sciences (SAVA) Stock Shouldnt Spook You TipRanks
09:30AM	2 Ultra-Safe Dividend Stocks to Own in 2023 Motley Fool
05:57AM	Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback? Motley Fool
02:56AM	Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs Barrons.com
Jan-24-23 05:45PM	Eli Lilly (LLY) Gains As Market Dips: What You Should Know Zacks
09:30AM	Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet Zacks
07:25AM	Eli Lilly to invest $450 million more to expand diabetes drug plant capacity Reuters
07:15AM	UPDATE 2-Eli Lilly to invest $450 mln more to expand capacity as obesity drug decision looms Reuters
06:44AM	Eli Lilly to invest $450 mln to expand diabetes drug plant capacity Reuters
06:42AM	Eli Lilly to invest additional $450 million in Research Triangle Park facility, to add at least 100 jobs MarketWatch
06:30AM	Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park PR Newswire
Jan-23-23 11:41PM	Eli Lilly to expand Durham campus with 100-job manufacturing facility American City Business Journals
10:38AM	Lilly (LLY) Jardiance Kidney Disease sNDA Gets FDA Acceptance Zacks
09:38AM	Concert (CNCE) Stock Up 17% Last Week on Sun Pharma Buyout Offer Zacks
Jan-20-23 04:17PM	Wayfair, Ally, Netflix, Goldman Sachs, and More Stock Market Movers Today Barrons.com
04:11PM	FDA rejects Eli Lillys accelerated approval application for Alzheimers drug Yahoo Finance Video
04:04PM	In A Stunner, Eli Lilly Stock Falls After FDA Delivers A Blow To Its Alzheimer's Drug Investor's Business Daily
03:08PM	These Stocks Are Moving the Most Today: Wayfair, Ally, SVB Financial, Goldman Sachs, and More Barrons.com
01:15PM	Eli Lilly Stock Falls After FDA Rejects Alzheimer's Drug Candidate The Wall Street Journal
12:52PM	FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug Zacks
12:08PM	FDA Rejects Lillys Alzheimers Drug Candidate, Seeks More Data The Wall Street Journal
10:51AM	Analyst Report: Eli Lilly and Company Morningstar Research
09:57AM	FDA Seeks More Data on Lillys Alzheimers Drug Candidate The Wall Street Journal
09:23AM	Pharma Stock Roundup: LLY's Donanemab Gets FDA's CRL, MRNA RSV Jab Study Succeeds Zacks
09:00AM	US FDA accepts supplemental New Drug Application for Jardiance® for adults with chronic kidney disease PR Newswire
08:37AM	Eli Lilly's (NYSE:LLY) Upcoming Dividend Will Be Larger Than Last Year's Simply Wall St.
05:34AM	Eli Lilly Stock Slips Lower As FDA Rejects Fast Track Approval For Alzheimer's Drug TheStreet.com
05:30AM	Lilly shares slip after FDA rejects early Alzheimer's drug approval Investing.com
05:22AM	FDA Rejects Eli Lilly's Donanemab For Alzheimer's Disease, Needs More Data Benzinga
05:12AM	Stocks Mixed, Netflix, Costco, Nordstrom, Eli Lilly In Focus - Five Things To Know TheStreet.com
Jan-19-23 06:46PM	UPDATE 3-Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug Reuters
06:18PM	Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug Reuters
06:00PM	U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab PR Newswire
10:00AM	Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement PR Newswire
08:00AM	Quite a few insiders invested in Eli Lilly and Company (NYSE:LLY) last year which is positive news for shareholders Simply Wall St.
Jan-18-23 05:45PM	Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know Zacks

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jonsson Patrik	EVP&Pres, LLY Imm, LLY USA&CCO	Feb 01	Option Exercise	0.00	6,690	0	38,052	Feb 03 04:48 PM
Hakim Anat	EVP, GC & Secretary	Feb 01	Option Exercise	0.00	7,646	0	16,510	Feb 03 04:45 PM
Ricks David A	President, Chair, and CEO	Feb 01	Option Exercise	0.00	47,786	0	413,102	Feb 03 04:41 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01	Option Exercise	0.00	7,264	0	57,616	Feb 03 05:04 PM
Skovronsky Daniel	EVP, CS&MO & Pres., LRL	Feb 01	Option Exercise	0.00	15,675	0	94,234	Feb 03 05:01 PM
Pusey Leigh Ann	EVP, Corp. Affairs & Comm.	Feb 01	Option Exercise	0.00	3,154	0	29,398	Feb 03 04:57 PM
Norton Johna	EVP, Global Quality	Feb 01	Option Exercise	0.00	2,102	0	32,342	Feb 03 04:54 PM
Mason Michael B	EVP & Pres., Lilly Diabetes	Feb 01	Option Exercise	0.00	6,690	0	34,196	Feb 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Dec 02	Sale	372.88	49,089	18,304,192	102,948,810	Dec 05 12:15 PM
LILLY ENDOWMENT INC	10% Owner	Dec 01	Sale	371.54	160,911	59,785,493	102,997,899	Dec 02 11:29 AM
Kearny Acquisition Corp	10% Owner	Nov 30	Buy	12.50	29,992,668	374,908,350	100	Dec 01 04:10 PM
LILLY ENDOWMENT INC	10% Owner	Nov 07	Sale	363.94	63,585	23,141,044	103,158,810	Nov 08 01:45 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04	Sale	363.77	1,336	485,996	103,222,395	Nov 07 02:34 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03	Sale	362.08	133,948	48,499,892	103,223,731	Nov 04 12:21 PM
LILLY ENDOWMENT INC	10% Owner	Nov 02	Sale	362.07	6,131	2,219,851	103,357,679	Nov 03 12:16 PM
LILLY ENDOWMENT INC	10% Owner	Oct 21	Sale	338.32	161,936	54,786,634	103,363,810	Oct 24 04:10 PM
LILLY ENDOWMENT INC	10% Owner	Oct 19	Sale	335.48	3,547	1,189,933	103,525,746	Oct 20 02:17 PM
LILLY ENDOWMENT INC	10% Owner	Oct 18	Sale	334.03	12,042	4,022,377	103,529,293	Oct 19 02:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 17	Sale	335.41	79,624	26,706,632	103,541,335	Oct 18 03:45 PM
LILLY ENDOWMENT INC	10% Owner	Oct 14	Sale	333.95	3,187	1,064,307	103,620,959	Oct 17 01:02 PM
LILLY ENDOWMENT INC	10% Owner	Oct 12	Sale	333.50	400	133,400	103,624,146	Oct 13 05:36 PM
Weems Alonzo	EVP, ERM & CECO	Oct 10	Sale	326.23	656	214,007	6,950	Oct 11 04:09 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06	Sale	334.54	149,264	49,934,082	103,624,546	Oct 07 03:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 28	Sale	335.07	101,631	34,053,650	103,773,810	Sep 29 01:56 PM
Zakrowski Donald A	Chief Accounting Officer	Sep 01	Sale	301.00	1,000	301,000	5,274	Sep 06 04:22 PM
TAI JACKSON P	Director	Aug 12	Buy	304.19	656	199,549	62,857	Aug 16 04:06 PM
Weems Alonzo	SVP, ERM & CECO	Aug 10	Sale	304.50	656	199,752	8,136	Aug 12 04:34 PM
LILLY ENDOWMENT INC	10% Owner	Jul 28	Sale	332.85	89,458	29,776,514	103,875,441	Jul 29 11:43 AM
LILLY ENDOWMENT INC	10% Owner	Jul 26	Sale	332.52	1,601	532,371	103,964,899	Jul 27 10:26 AM
LILLY ENDOWMENT INC	10% Owner	Jul 15	Sale	332.76	17,310	5,760,013	103,966,500	Jul 18 01:50 PM
LILLY ENDOWMENT INC	10% Owner	Jul 06	Sale	330.28	177,243	58,539,296	103,983,810	Jul 07 12:03 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28	Sale	329.01	900	296,109	104,161,053	Jun 29 11:31 AM
LILLY ENDOWMENT INC	10% Owner	Jun 27	Sale	329.05	41,857	13,772,837	104,161,953	Jun 28 01:54 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24	Sale	324.31	215,000	69,726,324	104,203,810	Jun 27 01:45 PM
LILLY ENDOWMENT INC	10% Owner	Jun 23	Sale	311.05	205,000	63,764,750	104,418,810	Jun 24 01:36 PM
LILLY ENDOWMENT INC	10% Owner	Jun 22	Sale	306.84	210,000	64,435,611	104,623,810	Jun 23 02:50 PM
Rau Diogo	SVP & CIDO	Jun 01	Option Exercise	0.00	7,560	0	7,560	Jun 02 06:41 PM
Zakrowski Donald A	Chief Accounting Officer	Jun 01	Sale	313.44	1,000	313,440	6,274	Jun 02 06:43 PM
LILLY ENDOWMENT INC	10% Owner	May 27	Sale	318.98	200,000	63,796,661	104,833,810	May 31 02:44 PM
LILLY ENDOWMENT INC	10% Owner	May 26	Sale	311.27	178,390	55,526,821	105,033,810	May 27 10:58 AM
LILLY ENDOWMENT INC	10% Owner	May 25	Sale	308.95	41,610	12,855,267	105,212,200	May 26 11:40 AM
LILLY ENDOWMENT INC	10% Owner	May 24	Sale	305.98	100,000	30,597,961	105,253,810	May 25 11:37 AM
LILLY ENDOWMENT INC	10% Owner	May 23	Sale	302.73	118,856	35,981,664	105,353,810	May 24 12:51 PM
LILLY ENDOWMENT INC	10% Owner	May 18	Sale	302.00	700	211,400	105,472,666	May 19 10:08 AM
LILLY ENDOWMENT INC	10% Owner	May 17	Sale	302.26	19,683	5,949,343	105,473,366	May 18 01:11 PM
LILLY ENDOWMENT INC	10% Owner	May 16	Sale	302.53	80,761	24,432,993	105,493,049	May 17 11:03 AM
LILLY ENDOWMENT INC	10% Owner	Apr 08	Sale	310.79	139,045	43,213,795	105,573,810	Apr 11 02:26 PM
LILLY ENDOWMENT INC	10% Owner	Apr 07	Sale	309.82	70,955	21,982,985	105,712,855	Apr 08 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Apr 06	Sale	300.92	51,851	15,603,021	105,783,810	Apr 07 12:44 PM
LILLY ENDOWMENT INC	10% Owner	Apr 05	Sale	293.86	113,756	33,428,339	105,835,661	Apr 06 02:35 PM
LILLY ENDOWMENT INC	10% Owner	Apr 04	Sale	293.15	39,393	11,548,137	105,949,417	Apr 05 02:31 PM
LILLY ENDOWMENT INC	10% Owner	Apr 01	Sale	292.38	165,376	48,352,781	105,988,810	Apr 04 02:34 PM
LILLY ENDOWMENT INC	10% Owner	Mar 30	Sale	292.03	2,500	730,075	106,154,186	Mar 31 12:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 29	Sale	292.39	4,341	1,269,254	106,156,686	Mar 30 04:37 PM
LILLY ENDOWMENT INC	10% Owner	Mar 28	Sale	292.15	7,538	2,202,264	106,161,027	Mar 29 02:14 PM
LILLY ENDOWMENT INC	10% Owner	Mar 21	Sale	292.43	35,245	10,306,604	106,168,565	Mar 22 03:41 PM
LILLY ENDOWMENT INC	10% Owner	Mar 18	Sale	288.18	210,000	60,518,363	106,203,810	Mar 21 01:12 PM
LILLY ENDOWMENT INC	10% Owner	Mar 17	Sale	283.80	220,000	62,435,453	106,413,810	Mar 18 11:48 AM
Jonsson Patrik	SVP&Pres, LLY Imm, LLY USA&CCO	Mar 17	Sale	277.20	673	186,556	31,362	Mar 17 04:12 PM
LILLY ENDOWMENT INC	10% Owner	Mar 15	Sale	274.96	220,075	60,511,869	106,633,810	Mar 16 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Mar 14	Sale	269.39	173,085	46,626,915	106,853,885	Mar 15 02:13 PM
LILLY ENDOWMENT INC	10% Owner	Mar 11	Sale	269.05	21,840	5,875,986	107,026,970	Mar 14 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Mar 10	Sale	266.45	184,982	49,287,539	107,048,810	Mar 11 12:04 PM
LILLY ENDOWMENT INC	10% Owner	Mar 09	Sale	266.52	20,018	5,335,148	107,233,792	Mar 10 12:39 PM
LILLY ENDOWMENT INC	10% Owner	Mar 04	Sale	262.24	210,000	55,070,947	107,253,810	Mar 07 01:27 PM
Hakim Anat	SVP, GC & Secretary	Mar 01	Option Exercise	0.00	7,929	0	12,364	Mar 03 06:36 PM
Runge Marschall S	Director	Mar 01	Buy	246.78	202	49,850	15,436	Mar 07 05:06 PM
Jonsson Patrik	SVP&Pres, LLY Imm, LLY USA&CCO	Mar 01	Sale	247.56	675	167,103	32,035	Mar 03 06:30 PM
Zakrowski Donald A	Chief Accounting Officer	Feb 25	Sale	243.84	1,660	404,774	7,274	Feb 28 04:38 PM
Van Naarden Jacob	SVP, CEO LoxoONC, Pres LlyONC	Feb 16	Option Exercise	0.00	5,461	0	10,153	Feb 17 04:44 PM
Yuffa Ilya	SVP & President, LLY Int'l	Feb 16	Sale	242.58	1,000	242,580	11,624	Feb 17 04:40 PM
Yuffa Ilya	SVP & President, LLY Int'l	Feb 15	Sale	237.45	1,000	237,450	12,624	Feb 17 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience